FindMyKOL

James Zidar

Basic profile

Rex Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionRaleigh, NC · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLFindMyKOL type: NationalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

James Zidar is a Cardiology physician affiliated with Rex Hospital. OpenAlex indexes 82 publications with 4,576 citations (h-index 25).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
82publications

Publications indexed by OpenAlex. Counts exclude supporting files.

4,576citations

Citations across these publications.

25h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
21companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Janssen
    Program year202515 paymentsResearch
    $35,110
  • Shockwave Medical
    Program year20252 paymentsResearch
    $19,959
  • Boston Scientific
    Program year20251 paymentResearch
    $18,850
All 53 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    78.3%
    Beta blocker19.1%
    Metoprolol Succinate67%Metoprolol Tartrate14%Carvedilol13%Atenolol4%Sotalol2%Labetalol Hcl1%
    Part D<11 patients
    Statin14.5%
    Rosuvastatin Calcium44%Atorvastatin Calcium40%Pravastatin Sodium10%Simvastatin6%
    Part D≥115 patients

    + 15 more classes in this area

  • Blood & clotting

    18.8%
    Factor Xa inhibitor9.7%
    Eliquis84%Xarelto17%
    Part D≥94 patients
    P2Y12 inhibitor8.1%
    Clopidogrel85%Prasugrel Hcl8%Brilinta7%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.1%
    Proton pump inhibitor1.3%
    Pantoprazole Sodium83%Omeprazole17%
    Part D<11 patients
    Potassium supplement0.6%
    Potassium Chloride100%
    Part D≥12 patients

    + 1 more class in this area

Where care is delivered (Part B)34.5% facility · 65.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”